Gestational trophoblastic disease

This article is in need of attention from an expert on the subject. WikiProject Medicine or the Medicine Portal may be able to help recruit one. (July 2008)

This article may require cleanup to meet Wikipedia's quality standards. Please improve this article if you can. (November 2007)

Gestational trophoblastic disease is any type of abnormal proliferation of trophoblasts during pregnancy.

Types

Types include:

• abnormal placenta, mostly due to abnormal fertilization
  • hydatidiform mole (HM)
• frank malignant tumors of trophoblast
  • invasive mole, choriocarcinoma (CCA)
  • placental site trophoblastic tumor (PSTT)
  • epithelioid trophoblastic tumor (ETT)
• not true neoplasms, representing abnormally formed placentas
  • exaggerated placenta site (EPS)
  • placental site nodule (PSN)

Treatment

Methotrexate and dactinomycin are among the chemotherapy drugs proposed for this condition.^[1]

See also

• Trophoblastic neoplasms

References

1. ^ Abrão RA, de Andrade JM, Tiezzi DG, Marana HR, Dos Reis FJ, Clagnan WS (2007). "Treatment for low-risk gestational trophoblastic disease: Comparison of single-agent methotrexate, dactinomycin and combination regimens". Gynecologic Oncology 108: 149. doi:10.1016/j.ygyno.2007.09.006. PMID 17931696. 

External links

• Molar Pregnancy
• MyMolarPregnancy.com Information about molar pregnancy and choriocarcinoma.
• Pathology of molar pregnancy
• EVERYTHING ABOUT MOLA, is the second highest treatment center in the world

This disease article is a stub. You can help Wikipedia by expanding it.